Probability of reduced renal function after contrast-enhanced CT: A model based on serum creatinine level, patient age, and estimated glomerular filtration rate

American Journal of Roentgenology

Volumn 193, Issue 2, 2009, Pages 494-500

  Herts, Brian R ^a   Schneider, Erika ^a   Obuchowski, Nancy ^a   Poggio, Emilio ^a   Jain, Anil ^a   Baker, Mark E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Contrast enhanced CT; Contrast induced nephropathy; Estimated glomerular filtration rate; IV contrast material; Modification of Diet in Renal Disease (MDRD) equation; Renal function

Indexed keywords

CONTRAST MEDIUM; CREATININE;

ADULT; AGE DISTRIBUTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RACE DIFFERENCE; RENOGRAPHY; RISK FACTOR; RISK MANAGEMENT; SEX RATIO;

AGE FACTORS; CHRONIC DISEASE; CONTRAST MEDIA; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PROBABILITY; ROC CURVE; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68149160864     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1908     Document Type: Article

References (28)

1. Weisbord SD, Chen H, Stone RA, et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 2006; 17:2871-2877 (Pubitemid 44484677)
2. McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 2006; 67:335-343 (Pubitemid 43346729)
3. Persson PB. Contrast-induced nephropathy. Eur Radiol 2005; 15[suppl 4]:D65-D69
4. McCullough PA, Adam A, Becker CR, et al.; CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006; 98:5K-13K
5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103:368-375 (Pubitemid 27506242)
6. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. N Engl J Med 1989; 320:143-149
7. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR 1991; 157:49-58
8. Gleeson TG, Bulugahahpitiya S. Contrast-induced nephropathy. AJR 2004; 183:1673-1689
9. Toprak O. Risk markers for contrast-induced nephropathy. Am J Med Sci 2007; 334:283-290
10. Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006; 41:815-821
11. Adolph E, Holdt-Lehmann B, Chatterjee T, et al. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coron Artery Dis 2008; 19:413-419
12. Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J 2008; 156:776-782
13. Morcos SK, Thomsen HS; European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003; 28:187-190
14. Toprak O, Mueller C. Differing definitions of contrast-induced nephropathy. Swiss Med Wkly 2005; 135:630; author reply, 630
15. Harjai KJ, Raizafa A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel grading system. Am J Cardiol 2008; 101:812-819
16. Levey AS, Coresh J, Balk E, et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139:137-147 [Erratum in Ann Intern Med 2003; 139:605] (Pubitemid 38129105)
17. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483 (Pubitemid 43855050)
18. Lameire N, Adam A, Becker CR, et al.; CIN Consensus Working Panel. Baseline renal function screening. Am J Cardiol 2006; 98:21K-26K
19. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR 2008; 191:376-382
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
21. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13:2140-2144 (Pubitemid 34790792)
22. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 2006; 15:276-284 (Pubitemid 43755803)
23. Thomas L, Huber AR. Renal function: estimation of glomerular filtration rate. Clin Chem Lab Med 2006; 44:1295-1302 (Pubitemid 44706706)
24. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305 (Pubitemid 39268908)
25. Elicker BM, Cypel YS, Weinreb JC. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR 2006; 186:1651-1658
26. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 2008; 3:1274-1281
27. Molitoris BA. Contrast nephropathy: are short-term outcome measures adequate for quantification of long-term renal risk? Nat Clin Pract Nephrol 2008; 4:594-595
28. Detrenis S, Mechi M, Bertolini L, Savazzi G. Contrast medium administration in the elderly patient: is advancing age an independent risk factor for contrast nephropathy after procedures? J Vasc Interv Radiol 2007; 18:177-185 (Pubitemid 46616690)